中性粒细胞是循环suPAR的主要来源并预测危重症结局
该前瞻性单中心非干预队列研究纳入87例危重症患者(44例脓毒症、43例非脓毒症),与48例标准治疗感染患者和27例健康对照比较,检测入ICU时和第3天免疫细胞亚群uPAR表达及血清suPAR浓度。健康对照几乎全部中性粒细胞和单核细胞表达uPAR,而危重症患者仅58%中性粒细胞表达uPAR,显著低于健康对照或标准治疗患者,同时血清suPAR显著升高。低中性粒细胞uPAR与高血清suPAR呈明确负相关,且两者均与危重症患者死亡率密切相关。体外实验显示脓毒症患者血清可诱导原代中性粒细胞uPAR表达及后续受体脱落,但对巨噬细胞无此作用。
要点
- 危重症患者仅58%中性粒细胞表达uPAR,显著低于健康对照或标准治疗感染患者,而血清suPAR显著升高。
- 低中性粒细胞uPAR与高血清suPAR呈明确负相关,支持中性粒细胞脱落uPAR是系统炎症中suPAR的主要来源。
- 低uPAR和高suPAR均与危重症患者死亡率密切相关,可作为预后标志物。
- 脓毒症患者血清可在体外诱导原代中性粒细胞uPAR表达及后续受体脱落,但对巨噬细胞无此作用。
- 入ICU时和第3天检测中性粒细胞uPAR和血清suPAR可能有助于危重症风险分层。
适用人群与场景
- 内科ICU收治的危重症患者87例(44例脓毒症、43例非脓毒症),与48例标准治疗感染患者和27例健康对照比较。
- 前瞻性单中心非干预队列研究,纳入场景为ICU入科时和第3天。
研究设计与关键结果
- 研究类型:前瞻性单中心非干预队列研究,纳入87例危重症患者(44例脓毒症、43例非脓毒症)、48例标准治疗感染患者和27例健康对照。
- 健康对照中uPAR(CD87)几乎表达于所有血中性粒细胞和单核细胞,淋巴细胞上极少表达。
- 危重症患者仅58%中性粒细胞表达uPAR,显著低于健康对照或标准治疗患者;单核细胞uPAR表达在ICU患者中维持。
- ICU患者血清suPAR水平显著升高;低中性粒细胞uPAR与高血清suPAR在标准治疗患者和ICU患者中呈明确负相关。
- 低uPAR和高suPAR均与危重症患者死亡率密切相关。
- 体外实验:脓毒症患者血清诱导原代中性粒细胞uPAR蛋白表达及后续受体脱落,但对巨噬细胞无此作用。
证据类型、等级与局限
- 证据类型:前瞻性单中心非干预队列研究及体外实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,中性粒细胞是系统炎症中脱落suPAR蛋白的主要来源;高suPAR水平和低中性粒细胞uPAR表达可预测ICU患者死亡率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Circulating levels of soluble urokinase plasminogen activation receptor (suPAR) have been proposed as a prognostic biomarker in patients with critical illness and sepsis. However, the origin of suPAR in sepsis has remained obscure. We investigated the potential cellular sources of suPAR by analyzing membrane-bound urokinase plasminogen activator receptor (uPAR, CD87) and evaluated its clinical relevance in critically ill patients.
METHODS: We studied 87 critically ill patients (44 with sepsis, 43 without sepsis) from the medical intensive care unit (ICU) in comparison to 48 standard care patients with infections and 27 healthy controls in a prospective single-center non-interventional cohort study. Cellular uPAR expression of different immune cell subsets (by flow cytometry from peripheral blood) and corresponding serum suPAR concentrations were determined upon ICU admission and at day 3. Furthermore, we analyzed the effects of serum from sepsis patients on the activation and uPAR cleavage of primary human neutrophils and macrophages in vitro.
RESULTS: In healthy controls, uPAR (CD87) expression was detected on nearly all blood neutrophils and monocytes, but only scarcely on lymphocytes. While uPAR expression on monocytes was maintained in ICU patients, only 58% of neutrophils from critically ill patients expressed uPAR, which was significantly lower than in healthy controls or standard care patients. Concomitantly, serum suPAR levels were significantly increased in ICU patients. We noted a clear inverse correlation between low neutrophilic uPAR and high serum suPAR in standard care and ICU patients, indicating that shedding of uPAR from activated neutrophils represents a main source of suPAR in systemic inflammation. Both low uPAR and high suPAR were closely associated with mortality in critically ill patients. Furthermore, serum from sepsis patients induced uPAR protein expression and subsequent receptor shedding on isolated primary neutrophils, but not on macrophages, in vitro.
CONCLUSIONS: The inverse correlation between low uPAR surface expression on neutrophils and high serum suPAR in critically ill patients supports that neutrophils are a main source of shed suPAR proteins in systemic inflammation. Furthermore, high suPAR levels and low neutrophilic uPAR expression predict mortality in ICU patients.
参考来源
- Gussen H, Hohlstein P, Bartneck M, et al. Neutrophils are a main source of circulating suPAR predicting outcome in critical illness. J Intensive Care. 2019. PMID: 31061709. doi:10.1186/s40560-019-0381-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。